#CHINA Chain of Danger

Preface: This extensive collection of materials about Wuhan, in  particular, and in China, in general, contributes to an understanding of how globalization, particularly with opaque dictatorships possessed of no moral center produces dangers to health, society, and money. Right now in this world-wide epidemic, major disruptions and death make that more evident. There must be quality controls enforced on any product produced by China as a great deal ranges from defective to dangerous. Components for final goods are shoddy and manufactured by oppressed workers. Wuhan was one center, apparently considered so vital, the Chinese did not cordon it off before the virus spread to threaten the world – a type of genocide. Although there are legitimate concerns about patent protection, etc., the International focus must be on quality and worker conditions. The current “trade war” exacerbates the problem rather than leads to negotiation. Wuhan, as demonstrated, exhibits inherent danger.  The extent of American “debt” to China manifests an interdependence which now must be systematically reviewed, produce policies, and negotiation. As illustrated below, this problem extends to involvement in many other countries, e.g. France.
A most important aspect is the silencing and death of the Doctor who first identified and tried to inform those who should know the existence of this new virulent highly transmissible virus – which might have lead to real prevention in China and abroad.
Censorship is not only deadly in the arts but this collection demonstrates dangerous in industry and science too. The great Czech writer, Ivan Klima, reflecting on Nazi and Communist control of Czech wrote in My Crazy Century, his memoir, “Dogmatists . . .  cleave wholeheartedly to some incontrovertible, infallible truth, they acquire the certainty – the conviction – that they have the right to judge and to condemn all who do not recognize their truth.” See, the problems about vaccines below.

Thought control, deemed necessary by dictators, expands into all intellectual fields including science. It also prevents proper oversight of the means of production.

The current acknowledgement of the growth in Chinese global power should include the principles and insights found in this selection. Its imposition of improper control creates not only bad but dangerous results. The proof is pointedly displayed here. ~ Preface by Jonathan A. Weiss

#WUHAN AND #CHINA THREATEN WORLD HEALTH AND QUALITY OF LIFE

#CNPGC China National Pharmaceutical Group Corp. known as
#Sinopharm  a Chinese state-owned enterprise Founded 1998  Beijing
#SanofiPasteur French vaccine company
#ELHTZ  High Tech Industrial Development Zone
#WELHTDZ #Wuhan East Lake High-Tech Development Zone
#Biolake International Vaccine Park
#WIV Wuhan Institute of Virology  of CAS was established in 1956

China National Pharmaceutical Group Corp. (#CNPGC) known as #Sinopharm is a Chinese state-owned enterprise.

Meth and Fentanyl come to the U.S. from Wuhan China

#Sanofi Pasteur, a world-known French vaccine company, signed cooperation agreement with China National Pharmaceutical Group and Wuhan East Lake Hi-tech Development Zone in France on Nov 25. It plans to co-create a production base in Biolake International Vaccine Park, with the aim of offering innovative technology and high-quality biological products worldwide.

The Wuhan National Bio-industry Base, also known as the #Biolake, is China’s second largest state-level biotech industrial base in view of overall strength, located in Wuhan East Lake High-tech Development Zone.

High Tech Industrial Development Zone
National Date Incorporated:1988
No 546. Luoyu Road, Wuhan, Hubei,430079
www.wehdz.gov.cn/structure/index.htm
sy***@*******ov.cn
(086)027-87804115
Copyright held by the General Office of Hubei Provincial People’s Government. All Rights Reserved.
Website Maintenance: The Editorial Office of Hubei Provincial People’s Government Official Web Portal,a subordinate unit of Hubei Daily Media Group;
Add: 181 Donghu Road, Wuchang District, Wuhan, Hubei

High Tech Industrial Development Zone is home to 42 universities, 22 state key laboratories, 24 national engineering technology centers, 56 national scientific research institutes, etc. Optical-electronics, telecommunications, and equipment manufacturing are the core industries of Wuhan East Lake High-Tech Development Zone (#ELHTZ) while software outsourcing and electronics are also encouraged.
#ELHTZ is China’s largest production centre for optical-electronic products with key players like Changfei Fiber-optical Cables (the largest fiber-optical cable maker in China), Fenghuo Telecommunications and Wuhan Research Institute of Post and Telecommunications (the largest research institute in optical telecommunications in China).
Wuhan #ELHTZ also represents the development centre for China’s laser industry with key players such as #HUST Technologies and Chutian Laser being based in the zone.
The base’s current tenants include eight of the world’s Top 500 companies, 16 listed companies and 258 high-level startup teams from home and abroad. It generates one billion yuan of taxes a year, has gathered more than 30,000 professionals, and is now a first-class park nationally.

When the #WIV Wuhan Institute of Virology of #CAS was established in 1956

its main research focus was on veterinary viruses and plant viruses that can be transmitted with common pests. After the outbreak of severe acute respiratory syndrome (#SARS) in China in 2002, #WIV has gradually taken on more research projects on human viruses such as hepatitis, AIDS, influenza and SARS following the demand of more home-grown research on human viruses in China. As a result, #WIV was in the national spotlight when construction of level-4 (BSL-4) laboratory finally finished this February, 12 years after its initial proposal.

It is the first #BSL-4 lab of China and its completion makes China the tenth country in the world to have the capacity to study dangerous viruses such as Ebola.

Wuhan has more undergraduate and graduate students than anywhere else in the world.
As a CAS institute, WIV’s strength lies in basic research, but it has also been collaborating with universities, hospitals, the Chinese Centre for Disease Control and start-up pharmaceutical companies to conduct multi-disciplinary research and transform results of basic research into medicine and therapies.

According to the director of WIV, Chen Xinwen, “in the past the best undergraduate science students and graduate students tended to choose to pursue their PhD training and post-docs abroad.
“Just like other CAS institutes, we are hoping to attract more of the best students to stay in China and study and work at WIV.”

In 2011, Zhang Qingjie, the president of WUT, decided it should focus on fostering international collaboration to improve the research capacity of the university. He hopes to do this by “by hiring young researchers that have extensive research training abroad,” he said. “We help them establish their own lab at #WUT and they would help WUT liaise with their former mentors to establish joint labs with foreign universities.” This was the university’s route to establishing the Joint Nano Key Laboratory, set up by Prof. Charles M. Lieber of Harvard University and Prof. Mai Liqiang, who is now the executive dean of WUT’s International School of Materials Science and Engineering.

Harvard University’s Professor Charles Lieber
Charles Lieber was arrested on the 28th of January, 2020. He was arrested on charges of making false statements to the U.S. Department of Defense and to Harvard investigators regarding his participation in China’s Thousand Talents Program. A program which has been criticized and deemed as a threat to national security. This program aims at giving Chinese government access to research works of foreign scientists and handsomely rewarding the scientists financially.
According to the complaint, Lieber lied to both the Department of Defense and the National Institutes of Health about his affiliation with Wuhan University of Technology, or WUT, and his involvement with China’s “Thousand Talents Plan,” a program designed to recruit Chinese ex-pats and foreign scientists to China.

Lieber also allegedly failed to disclose large sums of money he received from the Chinese government, including more than $1.5 million to start a lab at WUT and a salary of up to $50,000 per month, plus living expenses for his work at WUT.

PHILADELPHIA-(MaraviPost)-Charles M. Lieber is an American chemist who was born on the 9th of April 1959 in Philadelphia, Pennsylvania, United States. He got his education from Franklin & Marshall College and Stanford University, He is professor in Harvard University. He is a pioneer in nanoscience and nanotechnology. Lieber has published over 400 papers in peer-reviewed journals and has edited and contributed to many books on nanoscience. Thomson Reuters named him the leading chemist in the world for the decade 2000-2010 in 2011 as a result of his impact on scientific publications. He has also received other awards in the field of science.

HUST, HZAU, CUG, SCUN and WIV are enthusiastic about hiring international researchers and have been able to do so through various global recruitment programmes that have emerged from China’s central and provincial governments since 2011.

These programmes that provide earmarked funding and preferential policies to lure foreign researchers to Wuhan. Zhang believes that “foreign scientists bring fresh viewpoints to our university and they are instrumental in transforming Chinese universities into internationally competitive research institutions.”

One of these recruitment programmes is the “Hundred Talents Program”, started by CAS, which provides three million RMB (US$0.5 million) for qualified researchers with more than four years of experience abroad who want to move back to China. The money can be used as start-up research funding. Since 1994, more than 1000 researchers have benefited from this highly selective programme. Unlike CAS institutes, which are under the jurisdiction of Ministry of Science and Technology, most of the top universities in China are under the supervision of Ministry of Education so they are not able to participate in the “Hundred Talents Program”. But universities and technology companies can use similar programs such as “Thousand Talents Program” to help attract foreign researchers.

China National Pharmaceutical Group founded 1998

Key people  Guo Jianxin (Chairman & Party Committee Secretary)

Mar 31, 2020

China’s biggest lab has 1500 strains of viruses. Is China equipped to handle these samples? Is anyone keeping a check on the Chinese labs?

The lab — the Wuhan National Biosafety Laboratory (Level 4) of the Chinese Academy of Sciences — works with and studies the world’s most dangerous pathogens such as Severe Acute Respiratory Syndrome (SARS), and Ebola. However, scientists had warned in 2017 that a dangerous virus could escape the lab.

Jan 24, 2020 According to Nature, some scientists outside China were worried about pathogens escaping, and the addition of a “biological dimension to geopolitical tensions” between China and other nations. Wuhan coronavirus: China was warned in 2017 that a deadly virus could escape its level 4 biohazard lab

“It will offer more opportunities for Chinese researchers, and our contribution on the BSL‑4-level pathogens will benefit the world,” says George Gao, director of the Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology in Beijing. There are already two BSL-4 labs in Taiwan, but the National Bio-safety Laboratory, Wuhan, would be the first on the Chinese mainland. But the complexity of the project, China’s lack of experience, difficulty in maintaining funding and long government approval procedures meant that construction wasn’t finished until the end of 2014.

2/27/17 After the 2003 SARS epidemic, China constructed the Wuhan National Biosafety Laboratory (Level 4) of the Chinese Academy of Sciences, in 2015.
The aim was to prepare for and respond to future infectious disease outbreaks.
Inside the Chinese lab poised to study world’s most dangerous pathogens Maximum-security biolab is part of plan to build network of BSL-4 facilities across China.
Editors’ note, January 2020: Many stories have promoted an unverified theory that the Wuhan lab discussed in this article played a role in the coronavirus outbreak that began in December 2019. Nature knows of no evidence that this is true; scientists believe the most likely source of the coronavirus to be an animal market.
https://www.nature.com/news/inside-the-chinese-lab-poised-to-study-world-s-most-dangerous-pathogens-1.21487

Jan 24, 2020 Wuhan coronavirus: China was warned in 2017 that a deadly virus could escape its level 4 biohazard lab
After the 2003 SARS epidemic, China constructed the Wuhan National Biosafety Laboratory (Level 4) of the Chinese Academy of Sciences, in 2015. The aim was to prepare for and respond to future infectious disease outbreaks

Biosafety Level 4 Laboratory, Wuhan Institute of Virology, China

Pharmaceutical Industry Editor

The very first biosafety (level 4) BSL-4 laboratory in mainland China was opened in 2015, at a cost of around $44 million by the Wuhan Institute of Virology. The Wuhan BSL-4 laboratory took more than ten years to complete from its conception in 2003.
<https://pharma-industry-review.com/biosafety-level-4-laboratory-wuhan-institute-of-virology-china>

Biosafety (Level 4) BSL-4 Laboratory

The Wuhan BSL-4 laboratory is dedicated to the research of severe infectious diseases. Biosafety laboratories are divided into four biosafety levels: BSL-1, BSL-2, BSL-3, and BSL-4. The National Biosafety Level 4 Laboratory has the highest level of biological safety currently operated by human beings and is known as the “aircraft carrier” in the field of virology. Except for China, the only countries that currently have BSL-4 laboratories in the world are France, Canada, Germany, Australia, the United States, the United Kingdom, Sweden, and South Africa.

The Wuhan Biosafety Level 4 Laboratory adopts a design concept similar to the box-in-box of the BSL-4 laboratory in Lyon, France. The entire laboratory is suspended and divided into 4 floors. From bottom to top, the bottom layer is for the sewage treatment and life support system; the second layer is the core biosafety level 4 laboratory; the third layer is the filter system; the interlayer between the second and third layers is the pipe system; the uppermost layer is the air conditioning system.

Wuhan National Biosafety Level 4 Lab Location

The National biosafety laboratory is located only 30 kilometres away from the South China Seafood Wholesale Market. This “wet market” facilitating live poultry trade, is widely believed to be the epicenter for transmission of viral pathogenic coronaviruses, specifically the zoonotic transfer of Covid-19 to human beings. The Market in Wuhan closed on the 1st January 2020 after it was found to be the most likely starting point for the outbreak of this coronavirus. Consequently, the Wuhan Institute biosafety (level 4) BSL-4 laboratory is analyzing the 2019–2020 New Coronary Pneumonia (COVlD-19) outbreak.

In 2017 scientists such as U.S. molecular biologist Richard H. Ebright expressed concern of previous escapes of the SARS virus from Chinese high-level containment laboratories in Beijing and the pace and scale of China’s plans for expansion into BSL–4 laboratories.

The Laboratory has strong ties to the Galveston National Laboratory in the University of Texas. In 2020, Ebright called the Institute a “world-class research institution that does world-class research in virology and immunology”.

The new coronavirus outbreak

In January 2020, the Institute of Virology was rumoured as a source for the 2019–20 coronavirus outbreak as a result of allegations of bioweapon research. According to a report by the Central News Agency quoting Bejing Today, Huang Yanling, a postgraduate student of the Wuhan Institute of Virology of the Chinese Academy of Sciences, was the first “patient zero” infected with the Wuhan pneumonia and began to spread the virus; however, researchers at the virus laboratory denied these claims and guaranteed that no one was infected by the virus.

The claim was debunked as a conspiracy theory by The Washington Post in a piece titled: “Experts debunk fringe theory linking China’s coronavirus to weapons research”.

The Post cited U.S. experts who explained why the Institute was not suitable for bioweapon research, that most countries had abandoned bioweapons as fruitless, and that there was no evidence that the virus was genetically engineered.

In February 2020, the New York Times reported that a team led by Shi Zhengli, a researcher at the Institute, were the first to identify, analyze and name the genetic sequence of the Novel coronavirus (2019-nCoV), and upload it to public databases for scientists around the world to understand.

During January and February 2020, the Institute was subject to further conspiracy theories, and concerns that it was the source of the outbreak through accidental leakage, which it publicly refuted. Members of the Institute’s research teams were also subject to various conspiracy theories, including Shi, who made various public statements defending the Institute.

Patient Zero Huang Yanling

The report quoting Beijing News today, states “The zero patient of Wuhan (New Crown) Viral Pneumonia is Huang Yanling, a researcher at Wuhan Institute of Virology and admitted to the Wuhan University Institute of Virology in 2012.” Published by the Wuhan Institute of Virology of the Chinese Academy of Sciences on November 4, 2011, the “2012 Recommended List of Exempted Postgraduates from the Examination for Proposed Admissions” shows that Huang Yanling is an academic master recommended by Southwest Jiaotong University.

According to the report, the Beijing News sought confirmation from Shi Zhengli, at Wuhan Virus Research Institute and Chen Quanzhang, a researcher at the influenza virus laboratory. Both said they were not sure whether the institute had a female graduate student named Huang Yanling, but could guarantee that nobody of the institute was infected.

In this regards to the reports that the outbreak started at the South China Seafood Market, Caixin reported the following statement was made by Shi Zhengli:

“The novel 2019 coronavirus is nature punishing the human race for keeping uncivilized living habits. I, Shi Zhengli, swear on my life that it has nothing to do with our laboratory”.

The exact source of the Wuhan coronavirus ( (2019-nCoV) outbreak is of yet unknown.

The Wuhan Institute of Virology

The Wuhan Institute of Virology established the Chinese Academy of Sciences Biosafety Research Center. The center was jointly constructed by the Chinese Academy of Sciences, the National Health Committee and the People’s Government of Hubei Province. Construction was approved in November 2018.

The scientific research layout includes the Center for Molecular Virology and Pathology, the Center for Analytical Microbiology and Nanobiology, the Center for Resources and Application of Microbial Toxins, and the Center for Emerging Infectious Diseases. There are a total of 34 research subject groups.

The Institutes Network

The Institute is also comprised of the National Collection Center for Microbial and Toxin Collection designated by the National Health Commission, the National African Swine Fever Regional Laboratory, and the State Key Laboratory of Virology (Co-constructed with Wuhan University), China-Dutch-French Joint Laboratory of Invertebrate Virology, Key Laboratory of Highly Pathogenic Pathogens and Biosafety of the Chinese Academy of Sciences, Hubei HIV Screening Laboratory, Hubei Province Viral Disease Engineering technology research center and other research technology platforms. China’s only “China Virus Herbarium” with modern display means was created, and it was the first batch of “National Youth Science and Technology Demonstration Bases for Science and Technology”. Virologica Sinica, an English-language journal hosted by Wuhan Virus, is included in international authoritative databases such as SCI and PubMed, with an impact factor of 2.467 in 2019. At the same time, Wuhan Institute of Virology is also the anchor unit of the Hubei Province and Wuhan Institute of Microbiology and the Youth Working Committee of the Chinese Immunological Society.

The management system has five functional departments, including the General Office, the Organizational Personnel Office, the Scientific Research Planning Office, the Finance Office and the Graduate Office. The support system includes technical support departments such as Wuhan National Biosafety Laboratory, Public Technical Service Center, Network Information Center, and the Editorial Department of “Chinese Virology (English)”.

Wuhan Institute of Virology currently has two graduate education programs for first-level disciplines in biology and basic medicine, and five secondary education graduate programs for biochemistry and molecular biology, microbiology, immunology, pathogenic biology, and biology and medicine. There are two post-doctoral research mobile stations in biology and basic medicine.

Wuhan Institute using remdesivir

In February 2020, the Wuhan Institute of Virology applied for a patent in China for the use of remdesivir, the experimental drug developed by Gilead Sciences to treat SARS and Ebola. The Wuhan Institute found that remdesivir inhibited the virus invitro. The move raised some concerns regarding international intellectual property rights. In a statement, the virology institute said it would not exercise its new Chinese patent rights “if relevant foreign companies intend to contribute to the prevention and control of China’s epidemic”.

Chinese President Xi Jinping orders crackdown over ‘appalling’ vaccine scandal 7/18/2018

WHAT DRUGS ARE MANUFACTURED IN CHINA?

WHAT DRUGS ARE WE HAVING PROBLEMS GETTING?

Pfizer Inc. manufactures, markets and/or distributes more than 318 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
find ketamine, lorazepam, morphine, hydromorphone and fentanyl products

Educational CyberPlayground®
Nethappenings 4-9-20 Articles and Videos
#Amazon #AntiTrust #Patriot, #GOP #DeVos #RichestPastors #CowboyMuseum, #intelligence, #SchoolShooting, #Security #China #CCP #2025 #coronavirus #bailouts #Harvard #Yale #USC, #testicularCancer #antiviralSpray #ChairmanMao #Compensation, #testicularDamage #Seman #Kusher #Supply-Chain, #Trump #Pirate #Fascist #Graft #VOTE #Fraud #TrumpHotel #CoronavirusBailout, #Privacy
– Virus snarls global drug trade